IL123653A0 - Chemokine inhibitor - Google Patents

Chemokine inhibitor

Info

Publication number
IL123653A0
IL123653A0 IL12365396A IL12365396A IL123653A0 IL 123653 A0 IL123653 A0 IL 123653A0 IL 12365396 A IL12365396 A IL 12365396A IL 12365396 A IL12365396 A IL 12365396A IL 123653 A0 IL123653 A0 IL 123653A0
Authority
IL
Israel
Prior art keywords
chemokine inhibitor
chemokine
inhibitor
Prior art date
Application number
IL12365396A
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of IL123653A0 publication Critical patent/IL123653A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses
IL12365396A 1995-09-29 1996-09-26 Chemokine inhibitor IL123653A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53732495A 1995-09-29 1995-09-29
US57571595A 1995-12-20 1995-12-20
PCT/US1996/015385 WO1997011714A1 (en) 1995-09-29 1996-09-26 Chemokine inhibitor

Publications (1)

Publication Number Publication Date
IL123653A0 true IL123653A0 (en) 1998-10-30

Family

ID=27065462

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12365396A IL123653A0 (en) 1995-09-29 1996-09-26 Chemokine inhibitor

Country Status (10)

Country Link
US (1) US5871740A (en)
EP (1) EP0862449A4 (en)
JP (1) JPH11514861A (en)
KR (1) KR19990063653A (en)
AU (1) AU713661B2 (en)
CA (1) CA2232706A1 (en)
IL (1) IL123653A0 (en)
NO (1) NO981268L (en)
NZ (1) NZ320889A (en)
WO (1) WO1997011714A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495515B1 (en) 1995-04-19 2002-12-17 Viron Therapeutics, Inc. Chemokine binding protein and methods of use therefor
EP1034789A1 (en) * 1996-05-22 2000-09-13 University Of Alberta Type-2 chemokine binding proteins and methods of use therefor
DK0901379T3 (en) * 1996-05-22 2000-12-27 Univ Alberta Type 2 chemokine binding proteins and methods for their use
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6589933B1 (en) 1999-04-02 2003-07-08 Viron Therapeutics, Inc. Myxoma chemokine binding protein
US6894155B2 (en) 2000-10-11 2005-05-17 Viron Therapeutics Nucleic acid molecules and polypeptides for immune modulation
DE60128950T2 (en) 2000-12-04 2008-02-28 Viron Therapeutics, Inc., London Immunomodulatory protein derived from Yaba monkey tumor virus
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
US20040241163A1 (en) * 2001-04-05 2004-12-02 Thomas Shenk Compositions and methods for treating inflammation and related conditions
US20020165161A1 (en) * 2001-05-04 2002-11-07 Surromed, Inc. Chemokine-binding proteins for treating congestive heart failure
WO2003005953A2 (en) * 2001-07-12 2003-01-23 Immunex Corporation Viral proteins capable of binding lar
US7858297B2 (en) * 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
EP2269619A1 (en) 2002-08-12 2011-01-05 Jennerex Biotherapeutics ULC Methods and compositions concerning poxviruses and cancer
JP2007527193A (en) * 2002-12-10 2007-09-27 アンドキューブ ソシエタ パー アクシオン シンプリフィー THAP protein as a nuclear receptor for chemokines and its role in transcriptional regulation, cell proliferation, and cell differentiation
GB0304531D0 (en) * 2003-02-27 2003-04-02 Isis Innovation Treatment
CA2621982C (en) * 2005-09-07 2017-11-28 Jennerex Biotherapeutics Ulc Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses
US8980246B2 (en) 2005-09-07 2015-03-17 Sillajen Biotherapeutics, Inc. Oncolytic vaccinia virus cancer therapy
AU2007227218A1 (en) 2006-03-22 2007-09-27 Viral Logic Systems Technology Corp. Methods for identifying polypeptide targets and uses thereof for treating immunological diseases
KR20080084528A (en) * 2007-03-15 2008-09-19 제네렉스 바이오테라퓨틱스 인크. Oncolytic vaccinia virus cancer therapy
ES2848650T3 (en) 2009-09-14 2021-08-11 Sillajen Biotherapeutics Inc Combination cancer therapy with vaccinia oncolytic virus
CN103429258B (en) 2011-01-04 2016-03-09 新罗杰公司 By use oncolytic vaccinia virus generate for tumor antigen antibody and generate tumour-specific CDC

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157110A (en) * 1988-08-20 1992-10-20 The Government Of The United States Of America Synthetic, anti-complement protein
CH682669A5 (en) * 1989-03-08 1993-10-29 Health Research Inc recombinant virus engineered to express a gene product in a host, corresponding methods and vaccine.
GB8915870D0 (en) * 1989-07-11 1989-08-31 Nat Res Dev Dna coding for a polypeptide signal sequence in vaccinia virus
JP3664176B2 (en) * 1992-11-10 2005-06-22 ジェネンテック・インコーポレーテッド C-C CKR-1, C-C chemokine receptor
JPH10508742A (en) * 1994-08-23 1998-09-02 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド Human chemokine polypeptide

Also Published As

Publication number Publication date
AU7372596A (en) 1997-04-17
WO1997011714A1 (en) 1997-04-03
US5871740A (en) 1999-02-16
KR19990063653A (en) 1999-07-26
AU713661B2 (en) 1999-12-09
NO981268L (en) 1998-05-29
NO981268D0 (en) 1998-03-20
NZ320889A (en) 2000-09-29
EP0862449A4 (en) 1998-11-11
CA2232706A1 (en) 1997-04-03
EP0862449A1 (en) 1998-09-09
JPH11514861A (en) 1999-12-21

Similar Documents

Publication Publication Date Title
EP0835109A4 (en) Pyridinone-thrombin inhibitors
PL321759A1 (en) Novel thrombosin inhibitors
EP0820453A4 (en) Thrombin inhibitors
PL326508A1 (en) Protease inhibitors
IL123653A0 (en) Chemokine inhibitor
PL331338A1 (en) Thiosulphonamidic metaloprotease inhibitors
PL316669A1 (en) Angiogenesis inhibitors
PL331803A1 (en) Bidonoric metaloprotease inhibitors
PL325013A1 (en) Profile endopepsidase inhibitors
HU9503783D0 (en) Squvalen syntetase inhibitors
IL117437A0 (en) Novel thrombin inhibitors
GB9502985D0 (en) Enzyme inhibitors
AU6049796A (en) Lysyloxidase inhibitors
DE69523450D1 (en) Inhibitor
IL112244A0 (en) Novel inhibitor
ZA939480B (en) Enzyme inhibitor
AU6860296A (en) Cycloanthelmintic inhibitors
AP9600802A0 (en) Libricant
GB9515854D0 (en) Spider inhibitor
IL127551A0 (en) Chemokine beta-15
CA76097S (en) Can
AU1105P (en) DALESE Metrosideros excelsus
ZA968947B (en) Angiogenesis inhibitor
GB9508432D0 (en) Corrosion inhibitors
ZA968922B (en) Thrombin inhibitors